Furthermore, FGF21 attenuates acute myocardial infarction by upregulation of adiponectin in mice (14), and a high circulating FGF21 level is considered as a prognostic biomarker in patients with AMI (32, 33). The gene discussed is ADIPOQ; the disease is myocardial infarction.